Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 140.50
+6.00 (4.46%)
Sep 14, 2026, 1:24 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 602.35 million as of September 11, 2026.
Market Cap
602.35M
Enterprise Value
497.61M
Revenue
24.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
140.50
ChartMarket Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 602.35M, an increase of 223.14%. That is a compound annual growth rate of 287.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 602.35M | 173.93% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.50B |
| Thor Medical ASA | 1.99B |
| Nykode Therapeutics AS | 1.29B |
| ArcticZymes Technologies ASA | 1.08B |
| Lytix Biopharma ASA | 645.96M |
| Zelluna ASA | 602.98M |
| SoftOx Solutions AS | 312.22M |
| Aqua Bio Technology ASA | 75.14M |